Related Experiment Video

Updated: Aug 26, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Pathogenesis and treatment of hepatitis C virus-related liver diseases

Kyuichi Tanikawa1

  • 1International Institute for Liver Research, Kurume Research Center, 2432-3 Aikawa-machi, Kurume 839-0861, Japan. tanikawa@kurume.ktarn.or.jp

Hepatobiliary & Pancreatic Diseases International : HBPD INT
|February 19, 2004
PubMed

Insights

Hepatitis C virus (HCV) infection causes liver inflammation and hepatocellular carcinoma (HCC) through immune changes and oxidative stress. Understanding HCV pathogenesis is key for effective treatment, including interferon (IFN) therapy and oxidative stress management.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Comprehensive reviews on hepatitis C virus (HCV)-related liver disease pathogenesis are scarce.
  • HCV infection frequently leads to persistent liver inflammation and hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To review the pathogenesis of HCV-related liver diseases.
  • To discuss current and potential treatment strategies for HCV-related liver diseases.

Main Methods:

  • Review of existing literature, with a focus on Japanese studies.
  • Analysis of immunological alterations and oxidative stress mechanisms in HCV infection.

Main Results:

  • HCV infection is linked to immunological alterations and hepatocyte oxidative stress, contributing to HCC development.
  • Interferon (IFN) therapy is used for HCV elimination, chronic liver disease treatment, and HCC prevention/treatment.
  • Oxidative stress management is crucial for non-responders to IFN therapy.

Conclusions:

  • Understanding the pathogenesis of HCV-related liver diseases is essential for successful treatment outcomes.
  • Integrated treatment approaches addressing viral elimination, inflammation, and oxidative stress are necessary.
Abstract

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...